High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells

Journal of Virology

Volumn 72, Issue 11, 1998, Pages 8873-8883

  Mochizuki, Hideki ^a   Schwartz, Joan P ^a   Tanaka, Koichi ^b   Brady, Roscoe O ^a   Reiser, Jakob ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; INTEGRASE; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE TARGETING; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; SKIN FIBROBLAST; SPUMA VIRUS; VIRUS REPLICATION;

EID: 0031686754     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.11.8873-8883.1998     Document Type: Article

References (65)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70:2581-2585.
3. Baron, M., J. P. Reyes, D. Stassi, and G. Tiraby. 1992. A selectable bifunctional β-galactosidase::phleomycin resistance fusion protein as a potential marker for eukaryotic cells. Gene 114:239-243.
4. Boshart, M., F. Weber, G. Jahn, K. Dorsch-Häsler, B. Fleckenstein, and W. Schaffner. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521-530.
5. Buchschacher, G. L., Jr., and A. T. Panganiban. 1992. Human immunodeficiency virus vectors for inducible expression of foreign genes. J. Virol. 66:2731-2739.
6. Canivet, M., A. D. Hoffman, D. Hardy, J. Sernatinger, and J. A. Levy. 1990. Replication of HIV-1 in a wide variety of animal cells following phenotypic mixing with murine retroviruses. Virology 178:543-551.
7. Carroll, R., J.-T. Lin, E. J. Dacquel, J. D. Mosca, D. S. Burke, and D. C. St. Louis. 1994. A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines. J. Virol. 68:6047-6051.
8. Chang, H. K., R. C. Gallo, and B. Ensoli. 1995. Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat protein. J. Biomed. Sci. 2:189-202.
9. Chesebro, B., K. Wehrly, and W. Maury. 1990. Differential expression in human and mouse cells of human immunodeficiency virus pseudotyped by murine retroviruses. J. Virol. 64:4553-4557.
10. Clever, J. L., and T. G. Parslow. 1997. Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation. J. Virol. 71:3407-3414.
11. Corbeau, P., G. Kraus, and F. Wong-Staal. 1996. Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable packaging cell line. Proc. Natl. Acad. Sci. USA 93:14070-14075.
12. DuBridge, R. B., P. Tang, H. C. Hsia, L. Phaik-Mooi, J. H. Miller, and M. P. Calos. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
13. Dunbar, C. E. 1996. Gene transfer to hematopoietic stem cells: implications for gene therapy of human disease. Annu. Rev. Med. 47:11-20.
14. Emerman, M. 1996. From curse to cure: HIV for gene therapy? Nat. Biotechnol. 14:943.
15. Englund, G., T. S. Theodore, E. O. Freed, A. Engelman, and M. Martin. 1995. Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. J. Virol. 69:3216-3219.
16. Flügel, R. M., A. Rethwilm, B. Maurer, and G. Darai. 1987. Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes. EMBO J. 6:2077-2084.
17. Gibbs, J. S., D. A. Regier, and R. C. Desrosiers. 1994. Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes. AIDS Res. Hum. Retroviruses 10:343-350.
18. Goepfert, P. A., K. L. Shaw, G. D. Ritter, Jr., and M. J. Mulligan. 1997. A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum. J. Virol. 71:778-784.
19. Huang, L.-M., A. Joshi, R. Wiley, J. Orenstein, and K.-T. Jeang. 1994. Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 13:2886-2896.
20. Kafri, T., U. Blömer, D. A. Peterson, F. H. Gage, and I. M. Verma. 1997. Sustained expression of genes delivered into liver and muscle by lentiviral vectors. Nat. Genet. 17:314-317.
21. Kim, V. N., K. Mitrophanous, S. M. Kingsman, and A. J. Kingsman. 1998. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72:811-816.
22. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66: 2232-2239.
23. Landau, N. R., K. Page, and D. R. Littman. 1991. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J. Virol. 65:162-169.
24. Lever, A., H. Göttlinger, W. Haseltine, and J. Sodroski. 1989. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol. 63:4085-4087.
25. Lever, A. M. L. 1996. HIV and other lentivirus-based vectors. Gene Ther. 3:470-471.
26. Lewis, P., M. Hensel, and M. Emerman. 1992. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11:3053-3058.
27. Lewis, P. F., and M. Emerman. 1994. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:510-516.
28. Lindemann, D., M. Bock, M. Schweizer, and A. Rethwilm. 1997. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J. Virol. 71:4815-4820.
29. Liu, M.-L., B. L. Winther, and M. A. Kay. 1996. Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J. Virol. 70:2497-2502.
30. Lusso, P., F. Di Marzo Veronese, B. Ensoli, G. Franchini, C. Jemma, S. E. DeRocco, V. S. Kalyanaraman, and R. C. Gallo. 1990. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science 247:848-852.
31. + cell line H9. AIDS Res. Hum. Retroviruses 5:253-255.
32. McBride, M. S., and A. T. Panganiban. 1996. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J. Virol. 70:2963-2973.
33. Mebatsion, T., M. J. Schnell, and K.-K. Conzelmann. 1995. Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles. J. Virol. 69:1444-1450.
34. Miller, A. D. 1990. Retrovirus packaging cells. Hum. Gene Ther. 1:5-14.
35. Miller, D. G., M. A. Adam, and A. D. Miller. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239-4242.
36. Mochizuki, H., and J. Reiser. Unpublished data.
37. Myers, G., B. Foley, J. W. Mellors, B. Korber, K.-T. Jeang, and S. Wain-Hobson. 1996. Human retroviruses and AIDS 1996. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N.Mex.
38. Naldini, L., U. Blömer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
39. Ott, D., R. Friedrich, and A. Rein. 1990. Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses. J. Virol. 64:757-766.
40. Page, K. A., N. R. Landau, and D. R. Littman. 1990. Construction and use of human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64:5270-5276.
41. Parolin, C., T. Dorfman, G. Palú, H. Göttlinger, and J. Sodroski. 1994. Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. J. Virol. 68:3888-3895.
42. Parolin, C., B. Taddeo, G. Palú, and J. Sodroski. 1996. Use of cis- and trans-acting viral regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes. Virology 222:415-422.
43. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
44. Poeschla, E., P. Corbeau, and F. Wong-Staal. 1996. Development of HIV vectors for anti-HIV gene therapy. Proc. Natl. Acad. Sci. USA 93:11395-11399.
45. Poznansky, M., A. Lever, L. Bergeron, W. Haseltine, and J. Sodroski. 1991. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. J. Virol. 65:532-536.
46. Pracyk, J. B., D. D. Hegland, and K. Tanaka. 1997. Effect of a dominant negative ras on myocardial hypertrophy by using adenoviral-mediated gene transfer. Surgery 122:404-411.
47. Ratner, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. A. Whitehorn, K. Baumeister, L. Ivanoff, S. R. Petteway, Jr., M. L. Pearson, J. A. Lautenberger, T. S. Papas, J. Ghrayeb, N. T. Chang, R. C. Gallo, and F. Wong-Staal. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313:277-284.
48. Ratner, L., A. Fisher, L. L. Jagodzinski, H. Mitsuya, R.-S. Liou, R. C. Gallo, and F. Wong-Staal. 1987. Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Res. Hum. Retroviruses 3:57-63.
49. Reiser, J., G. Harmison, S. Kluepfel-Stahl, R. O. Brady, S. Karlsson, and M. Schubert. 1996. Transduction of nondividing cells using pseudotyped defective high-liter HIV type 1 particles. Proc. Natl. Acad. Sci. USA 93:15266-15271.
50. Richardson, J. H., J. F. Kaye, L. A. Child, and A. M. L. Lever. 1995. Helper-free transfer of human immunodeficiency virus type 1 vectors. J. Gen. Virol. 76:691-696.
51. Roe, T., T. C. Reynolds, G. Yu, and P. O. Brown. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:2099-2108.
52. Schneider, R., M. Campbell, G. Nasioulas, B. K. Felber, and G. N. Pavlakis. 1997. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J. Virol. 71:4892-4903.
53. + cells by a recombinant human immunodeficiency virus retroviral vector. J. Clin. Investig. 88:1043-1047.
54. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
55. Spector, D. H., E. Wade, D. A. Wright, V. Koval, C. Clark, D. Jaquish, and S. A. Spector. 1990. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J. Virol. 64:2298-2308.
56. Springett, G. M., R. C. Moen, S. Anderson, R. M. Blaese, and W. F. Anderson. 1989. Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J. Virol. 63:3865-3869.
57. Srinivasakumar, N., N. Chazal, C. Helga-Maria, S. Prasad, M.-L. Hammarskjöld, and D. Rekosh. 1997. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J. Virol. 71:5841-5848.
58. Stevenson, M. 1996. Portals of entry: uncovering HIV nuclear transport pathways. Trends Cell Biol. 6:9-15.
59. Strair, R. K., D. J. Medina, C. J. Nelson, T. A. Graubert, and J. W. Mellors. 1993. Recombinant retroviral systems for the analysis of drug resistant HIV. Nucleic Acids Res. 21:4836-4842.
60. Taniwaki, T., S. P. Becerra, G. J. Chader, and J. P. Schwartz. 1995. Pigment epithelium-derived factor is a survival factor for cerebellar granule cells in culture. J. Neurochem. 64:2509-2517.
61. Tobey, R. A., J. G. Valdez, and H. A. Crissman. 1988. Synchronization of human diploid fibroblasts at multiple stages of the cell cycle. Exp. Cell Res. 179:400-416.
62. Verma, I. M., and N. Somia. 1997. Gene therapy - promises, problems and prospects. Nature 389:239-242.
63. Yu, H., A. B. Rabson, M. Kaul, Y. Ron, and J. P. Dougherty. 1996. Inducible human immunodeficiency virus type 1 packaging cell lines. J. Virol. 70:4530-4537.
64. Zhu, Z., S. S. L. Chen, and A. S. Huang. 1990. Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus. J. Acquired Immune Defic. Syndr. 3:215-219.
65. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15:871-875.